These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21732348)

  • 1. mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer.
    Bhutia SK; Das SK; Kegelman TP; Azab B; Dash R; Su ZZ; Wang XY; Rizzi F; Bettuzzi S; Lee SG; Dent P; Grant S; Curiel DT; Sarkar D; Fisher PB
    J Cell Physiol; 2012 May; 227(5):1805-13. PubMed ID: 21732348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clusterin isoforms differentially affect growth and motility of prostate cells: possible implications in prostate tumorigenesis.
    Moretti RM; Montagnani Marelli M; Mai S; Cariboni A; Scaltriti M; Bettuzzi S; Limonta P
    Cancer Res; 2007 Nov; 67(21):10325-33. PubMed ID: 17974975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia inducible factor-1α directly regulates nuclear clusterin transcription by interacting with hypoxia response elements in the clusterin promoter.
    Park J; Park SY; Shin E; Lee SH; Kim YS; Lee DH; Roh GS; Kim HJ; Kang SS; Cho GJ; Jeong BY; Kim H; Choi WS
    Mol Cells; 2014 Feb; 37(2):178-86. PubMed ID: 24599003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear clusterin accumulation during heat shock response: implications for cell survival and thermo-tolerance induction in immortalized and prostate cancer cells.
    Caccamo AE; Desenzani S; Belloni L; Borghetti AF; Bettuzzi S
    J Cell Physiol; 2006 Apr; 207(1):208-19. PubMed ID: 16331665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exon-skipping strategy by ratio modulation between cytoprotective versus pro-apoptotic clusterin forms increased sensitivity of LNCaP to cell death.
    Essabbani A; Garcia L; Zonetti MJ; Fisco T; Pucci S; Chiocchia G
    PLoS One; 2013; 8(2):e54920. PubMed ID: 23418433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small interfering RNA targeted to secretory clusterin blocks tumor growth, motility, and invasion in breast cancer.
    Niu Z; Li X; Hu B; Li R; Wang L; Wu L; Wang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Dec; 44(12):991-8. PubMed ID: 23099883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clusterin over-expression modulates proapoptotic and antiproliferative effects of 1,25(OH)2D3 in prostate cancer cells in vitro.
    Shannan B; Seifert M; Boothman DA; Tilgen W; Reichrath J
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):721-5. PubMed ID: 17224269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRM1 protein-mediated regulation of nuclear clusterin (nCLU), an ionizing radiation-stimulated, Bax-dependent pro-death factor.
    Leskov KS; Araki S; Lavik JP; Gomez JA; Gama V; Gonos ES; Trougakos IP; Matsuyama S; Boothman DA
    J Biol Chem; 2011 Nov; 286(46):40083-90. PubMed ID: 21953454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells.
    Zhong B; Sallman DA; Gilvary DL; Pernazza D; Sahakian E; Fritz D; Cheng JQ; Trougakos I; Wei S; Djeu JY
    Mol Cancer Ther; 2010 Jun; 9(6):1831-41. PubMed ID: 20501799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression.
    Wang Y; Wang X; Zhao H; Liang B; Du Q
    J Chemother; 2012 Dec; 24(6):348-57. PubMed ID: 23174100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clusterin gene is predominantly regulated by histone modifications in human colon cancer and ectopic expression of the nuclear isoform induces cell death.
    Deb M; Sengupta D; Rath SK; Kar S; Parbin S; Shilpi A; Pradhan N; Bhutia SK; Roy S; Patra SK
    Biochim Biophys Acta; 2015 Aug; 1852(8):1630-45. PubMed ID: 25917404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glyceryl trinitrate‑induced cytotoxicity of docetaxel‑resistant prostatic cancer cells is associated with differential regulation of clusterin.
    Bouaouiche S; Magadoux L; Dondaine L; Reveneau S; Isambert N; Bettaieb A; Jeannin JF; Laurens V; Plenchette S
    Int J Oncol; 2019 Apr; 54(4):1446-1456. PubMed ID: 30720069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chapter 4: Regulation of Clusterin activity by calcium.
    Pajak B; Orzechowski A
    Adv Cancer Res; 2009; 104():33-58. PubMed ID: 19878772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel nucleolar localization of clusterin and its associated functions in human oral cancers: An in vitro and in silico analysis.
    Kadam R; Harish M; Dalvi K; Teni T
    Cell Biochem Funct; 2021 Apr; 39(3):380-391. PubMed ID: 33155695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of autophagy to apoptosis switch triggered in prostate cancer cells by antitumor cytokine melanoma differentiation-associated gene 7/interleukin-24.
    Bhutia SK; Dash R; Das SK; Azab B; Su ZZ; Lee SG; Grant S; Yacoub A; Dent P; Curiel DT; Sarkar D; Fisher PB
    Cancer Res; 2010 May; 70(9):3667-76. PubMed ID: 20406981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GRP78 regulates clusterin stability, retrotranslocation and mitochondrial localization under ER stress in prostate cancer.
    Li N; Zoubeidi A; Beraldi E; Gleave ME
    Oncogene; 2013 Apr; 32(15):1933-42. PubMed ID: 22689054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clusterin is a short half-life, poly-ubiquitinated protein, which controls the fate of prostate cancer cells.
    Rizzi F; Caccamo AE; Belloni L; Bettuzzi S
    J Cell Physiol; 2009 May; 219(2):314-23. PubMed ID: 19137541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein.
    Criswell T; Klokov D; Beman M; Lavik JP; Boothman DA
    Cancer Biol Ther; 2003; 2(4):372-80. PubMed ID: 14508108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells.
    Lee JY; Kim HJ; Rho SB; Lee SH
    Oncotarget; 2016 Apr; 7(14):18541-57. PubMed ID: 26988917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells.
    Zoubeidi A; Ettinger S; Beraldi E; Hadaschik B; Zardan A; Klomp LW; Nelson CC; Rennie PS; Gleave ME
    Mol Cancer Res; 2010 Jan; 8(1):119-30. PubMed ID: 20068069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.